This website is funded by Jazz Pharmaceuticals, and contains promotional content. This content is intended for Healthcare Professionals only.

WELCOME TO THE DEFITELIO® (Defibrotide) PORTAL 

THIS WEBSITE IS FOR HEALTHCARE PROFESSIONALS ONLY

This website contains promotional information on Defitelio▼ (defibrotide) and has been developed in-line with EU marketing authorisation. Please consult local prescribing information for further information.

By entering this site, you are confirming that you are a healthcare professional within your selected country.

By clicking continue, you will be leaving the Defitelio EU website and directed to the #### website where the information is intended only for healthcare professionals within this country.

Adverse events should be reported. Healthcare professionals are asked to report any adverse events via their national reporting system (see Section 4.8 of SmPC). Adverse events should also be reported to Jazz Pharmaceuticals by email to medinfo-int@jazzpharma.com or phone via +353 1 968 1631 (may include an international call charge).


▼ - This medicinal product is subject to additional monitoring